Y-mAbs Therapeutics Inc (YMAB)
12.06
+0.05
(+0.42%)
USD |
NASDAQ |
May 31, 16:00
12.10
+0.04
(+0.33%)
After-Hours: 20:00
Y-mAbs Therapeutics Shareholders Equity (Quarterly): 99.19M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 99.19M |
December 31, 2023 | 100.98M |
September 30, 2023 | 100.15M |
June 30, 2023 | 104.68M |
March 31, 2023 | 107.83M |
December 31, 2022 | 109.22M |
September 30, 2022 | 107.90M |
June 30, 2022 | 131.40M |
March 31, 2022 | 157.47M |
December 31, 2021 | 180.11M |
September 30, 2021 | 210.84M |
June 30, 2021 | 234.32M |
March 31, 2021 | 252.22M |
Date | Value |
---|---|
December 31, 2020 | 105.84M |
September 30, 2020 | 116.51M |
June 30, 2020 | 146.01M |
March 31, 2020 | 175.33M |
December 31, 2019 | 198.90M |
September 30, 2019 | 85.94M |
June 30, 2019 | 108.38M |
March 31, 2019 | 125.51M |
December 31, 2018 | 140.53M |
September 30, 2018 | 155.03M |
June 30, 2018 | 65.52M |
December 31, 2017 | 82.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
85.94M
Minimum
Sep 2019
252.22M
Maximum
Mar 2021
141.66M
Average
112.87M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 24.86M |
Theriva Biologics Inc | 34.12M |
Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 123.32M |
Total Liabilities (Quarterly) | 24.13M |
Current Ratio | 6.150 |